HSBC Holdings’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
HSBC Holdings's ELV Position: Q2 2026 in Review
HSBC Holdings increased its Elevance Health (ELV) stake by 2.3% in Q2 2026, buying an estimated $4.38M and bringing the position to 522,886 shares worth $203M. The position accounts for 0.08% of the portfolio, ranked #219.
HSBC Holdings first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $480M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- HSBC Holdings held 522,886 shares of Elevance Health worth $203M as of Q2 2026.
- HSBC Holdings bought 11,819 Elevance Health shares in Q2 2026, an estimated $4.38M.
- Elevance Health made up 0.08% of HSBC Holdings's portfolio in Q2 2026, its #219 holding.
- HSBC Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- HSBC Holdings's Elevance Health position peaked at $480M in Q2 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.